[1]
Rao SSC, Bhagatwala J. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management. Clinical and translational gastroenterology. 2019 Oct:10(10):e00078. doi: 10.14309/ctg.0000000000000078. Epub
[PubMed PMID: 31584459]
[2]
Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Digestive diseases and sciences. 2008 Jun:53(6):1443-54
[PubMed PMID: 17990113]
Level 1 (high-level) evidence
[3]
Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova M. Small intestinal bacterial overgrowth syndrome. World journal of gastroenterology. 2010 Jun 28:16(24):2978-90
[PubMed PMID: 20572300]
[4]
Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. The Journal of clinical investigation. 1977 Jun:59(6):1158-66
[PubMed PMID: 864008]
[5]
Roland BC, Ciarleglio MM, Clarke JO, Semler JR, Tomakin E, Mullin GE, Pasricha PJ. Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO). Digestive diseases and sciences. 2014 Jun:59(6):1269-77. doi: 10.1007/s10620-014-3166-7. Epub 2014 May 3
[PubMed PMID: 24795035]
[6]
Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Thomas MC, Bolin TD. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. The American journal of gastroenterology. 2001 Feb:96(2):494-500
[PubMed PMID: 11232696]
[7]
Jones RM, Neish AS. Recognition of bacterial pathogens and mucosal immunity. Cellular microbiology. 2011 May:13(5):670-6. doi: 10.1111/j.1462-5822.2011.01579.x. Epub 2011 Feb 24
[PubMed PMID: 21352463]
[8]
Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. The American journal of clinical nutrition. 1999 May:69(5):1035S-1045S. doi: 10.1093/ajcn/69.5.1035s. Epub
[PubMed PMID: 10232646]
[9]
Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Alimentary pharmacology & therapeutics. 2011 May:33(9):1059-67. doi: 10.1111/j.1365-2036.2011.04625.x. Epub 2011 Mar 13
[PubMed PMID: 21395630]
[11]
Bouhnik Y, Alain S, Attar A, Flourié B, Raskine L, Sanson-Le Pors MJ, Rambaud JC. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. The American journal of gastroenterology. 1999 May:94(5):1327-31
[PubMed PMID: 10235214]
[12]
Hoog CM, Lindberg G, Sjoqvist U. Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC gastroenterology. 2007 Jul 18:7():29
[PubMed PMID: 17640373]
[13]
Greenson JK. The biopsy pathology of non-coeliac enteropathy. Histopathology. 2015 Jan:66(1):29-36. doi: 10.1111/his.12522. Epub
[PubMed PMID: 25234408]
[14]
Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz C C. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease. BMC gastroenterology. 2009 Jul 30:9():61. doi: 10.1186/1471-230X-9-61. Epub 2009 Jul 30
[PubMed PMID: 19643023]
[15]
Shindo K, Machida M, Koide K, Fukumura M, Yamazaki R. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepato-gastroenterology. 1998 Sep-Oct:45(23):1643-50
[PubMed PMID: 9840121]
[16]
Pai RK. A practical approach to small bowel biopsy interpretation: celiac disease and its mimics. Seminars in diagnostic pathology. 2014 Mar:31(2):124-36. doi: 10.1053/j.semdp.2014.02.006. Epub 2014 Feb 12
[PubMed PMID: 24815938]
[17]
Lakhani SV, Shah HN, Alexander K, Finelli FC, Kirkpatrick JR, Koch TR. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutrition research (New York, N.Y.). 2008 May:28(5):293-8. doi: 10.1016/j.nutres.2008.03.002. Epub
[PubMed PMID: 19083422]
[18]
Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infectious disease clinics of North America. 2010 Dec:24(4):943-59, viii-ix. doi: 10.1016/j.idc.2010.07.007. Epub
[PubMed PMID: 20937459]
[19]
Bongaerts GP, Tolboom JJ, Naber AH, Sperl WJ, Severijnen RS, Bakkeren JA, Willems JL. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microbial pathogenesis. 1997 May:22(5):285-93
[PubMed PMID: 9160298]
[20]
Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014 May:146(6):1513-24. doi: 10.1053/j.gastro.2014.01.020. Epub 2014 Jan 15
[PubMed PMID: 24440671]
[21]
Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, Schmulson M, Valdovinos M, Zakko S, Pimentel M. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. The American journal of gastroenterology. 2017 May:112(5):775-784. doi: 10.1038/ajg.2017.46. Epub 2017 Mar 21
[PubMed PMID: 28323273]
Level 3 (low-level) evidence
[22]
Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2006 Jan-Feb:25(1):6-10
[PubMed PMID: 16567886]
[23]
Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. The American journal of gastroenterology. 2002 May:97(5):1113-26
[PubMed PMID: 12014715]
[24]
King CE, Toskes PP. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology. 1986 Dec:91(6):1447-51
[PubMed PMID: 3770368]
[25]
Corazza GR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, Lecchini R, Avanzini P, Chezzi C, Gasbarrini G. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990 Feb:98(2):302-9
[PubMed PMID: 2295385]
[26]
Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Alimentary pharmacology & therapeutics. 2013 Oct:38(8):925-34. doi: 10.1111/apt.12479. Epub 2013 Sep 4
[PubMed PMID: 24004101]
Level 1 (high-level) evidence
[27]
Pimentel M, Chang C, Chua KS, Mirocha J, DiBaise J, Rao S, Amichai M. Antibiotic treatment of constipation-predominant irritable bowel syndrome. Digestive diseases and sciences. 2014 Jun:59(6):1278-85. doi: 10.1007/s10620-014-3157-8. Epub 2014 May 1
[PubMed PMID: 24788320]
[28]
Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Novi M, Sottili S, Vitale G, Cesario V, Serricchio M, Cammarota G, Gasbarrini G, Gasbarrini A. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. The American journal of gastroenterology. 2008 Aug:103(8):2031-5
[PubMed PMID: 18802998]
[29]
Pimentel M, Constantino T, Kong Y, Bajwa M, Rezaei A, Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Digestive diseases and sciences. 2004 Jan:49(1):73-7
[PubMed PMID: 14992438]
[30]
Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, Paterson C, Bortey E, Forbes WP. Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology. 2016 Dec:151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13
[PubMed PMID: 27528177]
[31]
Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut and liver. 2017 Mar 15:11(2):196-208. doi: 10.5009/gnl16126. Epub
[PubMed PMID: 28274108]
[32]
Losurdo G, Marra A, Shahini E, Girardi B, Giorgio F, Amoruso A, Pisani A, Piscitelli D, Barone M, Principi M, Di Leo A, Ierardi E. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis. Neurogastroenterology and motility. 2017 Jun:29(6):. doi: 10.1111/nmo.13028. Epub 2017 Feb 12
[PubMed PMID: 28191721]
Level 1 (high-level) evidence
[33]
Shah A, Morrison M, Burger D, Martin N, Rich J, Jones M, Koloski N, Walker MM, Talley NJ, Holtmann GJ. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary pharmacology & therapeutics. 2019 Mar:49(6):624-635. doi: 10.1111/apt.15133. Epub 2019 Feb 8
[PubMed PMID: 30735254]
Level 1 (high-level) evidence
[34]
Ziegler TR, Cole CR. Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure. Current gastroenterology reports. 2007 Dec:9(6):463-7
[PubMed PMID: 18377796]
[35]
Bohm M, Siwiec RM, Wo JM. Diagnosis and management of small intestinal bacterial overgrowth. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2013 Jun:28(3):289-99. doi: 10.1177/0884533613485882. Epub 2013 Apr 24
[PubMed PMID: 23614961]
[36]
Compare D, Pica L, Rocco A, De Giorgi F, Cuomo R, Sarnelli G, Romano M, Nardone G. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. European journal of clinical investigation. 2011 Apr:41(4):380-6. doi: 10.1111/j.1365-2362.2010.02419.x. Epub 2010 Dec 3
[PubMed PMID: 21128930]
[37]
Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. Journal of clinical gastroenterology. 2017 Apr:51(4):300-311. doi: 10.1097/MCG.0000000000000814. Epub
[PubMed PMID: 28267052]
Level 1 (high-level) evidence